According to Kura Oncology 's latest financial reports the company's current earnings (TTM) are -$0.16 B. In 2022 the company made an earning of -$0.14 B a decrease over its 2021 earnings that were of -$0.14 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$0.16 B | 12.36% |
2022 | -$0.14 B | 4.12% |
2021 | -$0.14 B | 45.57% |
2020 | -$89.63 M | 41.95% |
2019 | -$63.14 M | 4.46% |
2018 | -$60.45 M | 70.59% |
2017 | -$35.44 M | 28.57% |
2016 | -$27.56 M | 21.81% |
2015 | -$22.63 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$0.12 B | -27.42% | ๐บ๐ธ USA |